SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 30 filers reported holding SILENCE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $476,850 | -78.0% | 86,700 | -75.2% | 0.00% | -85.7% |
| Q1 2023 | $2,166,664 | -61.7% | 349,462 | -5.7% | 0.01% | -63.2% |
| Q4 2022 | $5,651,071 | +2.2% | 370,562 | -32.7% | 0.02% | -13.6% |
| Q3 2022 | $5,528,000 | +86.6% | 550,875 | +120.4% | 0.02% | +69.2% |
| Q2 2022 | $2,963,000 | -37.6% | 250,000 | 0.0% | 0.01% | -31.6% |
| Q1 2022 | $4,750,000 | -20.5% | 250,000 | 0.0% | 0.02% | -20.8% |
| Q4 2021 | $5,973,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,284,133 | $19,583,028 | 7.36% |
| TCG Crossover Management, LLC | 2,104,875 | $32,099,344 | 5.66% |
| M28 Capital Management LP | 145,900 | $2,224,975 | 2.12% |
| Lombard Odier Asset Management (Europe) Ltd | 3,218,200 | $49,077,550 | 1.99% |
| Lombard Odier Asset Management (USA) Corp | 3,875,734 | $50,594,057 | 1.29% |
| Deep Track Capital, LP | 1,951,580 | $29,761,595 | 1.25% |
| BVF INC/IL | 1,508,416 | $23,003,344 | 0.97% |
| Frazier Life Sciences Management, L.P. | 881,173 | $13,437,888 | 0.84% |
| Parkman Healthcare Partners LLC | 134,842 | $2,056,341 | 0.55% |
| CANTOR FITZGERALD, L. P. | 301,690 | $4,601 | 0.10% |